Glytec, an insulin management software company, has received $21 million in funding from Silicon Valley Bank, Savitr Capital and other private investors.
The company collected $9 million in debt financing from SVB and $12 million in equity investments led by Savitr positions, according to its announcement.
WHAT IT DOES
Glytec’s eGlycemic Management System is centered on its FDA-cleared...
